Skip to content
Screener

Operating margin at other companies

Schrodinger logo
SchrodingerSDGR
-59.2%-12.6pp
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-991.7%-13.7pp
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-88,031.9%-89,488pp
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
32.6%+24.0pp
Immunome logo
ImmunomeIMNM
-5,947.9%-12,002pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-103.9%-43.0pp

Other financials

Income statement

See full
Revenue$350.0K-48.3%
Operating income-$90.8M-18.2%
Net income-$83.7M-18.9%
EPS (diluted)-$0.410.0%

Balance sheet

See full
Cash & equivalents$121.2M+6.4%
Total debt$30.7M-10.3%
Total equity$890.0M+33.7%
Total assets$967.5M+32.7%

Cash flow

See full
Operating cash flow-$54.1M+2.1%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$4.3B+611%
Enterprise value$4.21B+702%
P/S415.9×+343×

Profitability

See full
Net margin-2,763.6%-568pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-36.8%-6.3pp
Debt / equity0.0×
Current ratio18.3×-2.7×

Where this comes from

Calculated from Relay Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338056

FAQ

What is Relay Therapeutics, Inc.'s operating margin?
Relay Therapeutics, Inc. (RLAY) reported operating margin of -2,999.4% in Q2 2026.
How has Relay Therapeutics, Inc.'s operating margin changed year-over-year?
Relay Therapeutics, Inc.'s operating margin increased by 26.9% year-over-year, from -4,105.6% to -2,999.4%.
What is the long-term trend for Relay Therapeutics, Inc.'s operating margin?
Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s operating margin has grown at a -36.4% compound annual growth rate (CAGR), from -12,040.2% to -1,971.5%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Ask your AI about Relay Therapeutics, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude